Lynx1 Capital Management, 10% Owner: TScan Therapeutics TCRX Buy · Filed 25/12/23

Trade details

Type: Insider buy
Amount: $5,608.8
Shares · price: 6,232 sh · $0.90 a share
Held after: 8,019,148 sh
Stock: TScan Therapeutics TCRX
Person: Lynx1 Capital Management10% Owner
Trade date: 25/12/23
Filed: 25/12/23
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.1%

TScan Therapeutics trades, last 26 weeks

What else happened in TScan Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/23~01/22

Lynx1 Capital Management's recent trades

Lynx1 Capital Management10% Owner
BuyPassage BIO
Buy
Passage BIO
PASG
$206.2K
50,055 sh
$206.2K
Filed 06/29
Traded 06/25
Lynx1 Capital Management10% Owner
BuyKorro Bio
Buy
Korro Bio
KRRO
$5,512
520 sh
$5,512
Filed 04/02
Traded 03/31
Lynx1 Capital Management10% Owner
BuyTScan Therapeutics
Buy
TScan Therapeutics
TCRX
$72.1K
80,069 sh
$72.1K
Filed 25/12/23
Traded 25/12/19
Lynx1 Capital Management10% Owner
BuyTScan Therapeutics
Buy
TScan Therapeutics
TCRX
$68K
75,500 sh
$68K
Filed 25/12/23
Traded 25/12/22
Lynx1 Capital Management10% Owner
BuyCullinan Therapeutics
Buy
Cullinan Therapeutics
CGEM
$1.4M
165,667 sh
$1.4M
Filed 25/10/30
Traded 25/10/28